Metabolic Brain Disease

, Volume 13, Issue 4, pp 351–360 | Cite as

Does Ammonia Contribute to Increased GABA-ergic Neurotransmission in Liver Failure?

  • E. Anthony Jones
  • Anthony S. Basile
Article

Abstract

The ammonia and GABAergic neurotransmission hypotheses of the pathogenesis of hepatic encephalopathy (HE) have appeared to be unrelated and perhaps mutually exclusive. Observations in animal models of fulminant hepatic failure, that are consistent with increased GABAergic inhibitory neurotransmission contributing to the manifestations of HE, include: (i) abnormal visual evoked potential waveforms that resemble those induced by GABAA/benzodiazepine (BZ) receptor complex agonists; (ii) GABAA/BZ receptor complex antagonist-induced ameliorations of encephalopathy; (iii) increased resistance to drugs which decrease GABAergic tone; and (iv) hypersensitivity of CNS neurons to depression by GABAA/BZ receptor complex agonists. Mechanisms of increased GABAergic tone in HE may include the following: (i) increased brain concentrations of natural BZs; and (ii) increased GABA concentrations in synaptic clefts, possibly due to increased blood-brain-barrier permeability to GABA and a decrease in GABAB receptor density. Both neuroelectrophysiological and behavioral data indicate that ammonia concentrations in the range 0.75-2 mM induce increased excitatory neurotransmission. In contrast, recently, ammonia concentrations in the range 0.15-0.75 mM, i.e. concentrations that commonly occur in plasma in precoma HE, have been shown: (i) to increase GABA-induced chloride current in cultured neurons; and (ii) to enhance synergistically the binding of GABAA/BZ receptor agonists. In addition, increased ammonia concentrations enhance synthesis of neurosteroids in astrocytes, and some neurosteroids potently augment GABAergic neurotransmission. Thus, the modestly elevated concentrations of ammonia, that commonly occur in liver failure, may contribute to the manifestations of HE by enhancing GABAergic inhibitory neurotransmission. This concept appears to unify the ammonia and GABAergic neurotransmission hypotheses.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Akwa, Y., Sananes, N., Gouezou, M., Robel, P., Baulieu, E.E. and Le Goascogne, C. (1993). Astrocytes and neurosteroids: metabolism of pregnenolone and dehydro-epiandrosterone. Regulation by cell density. J. Cell. Biol. 12:135–143.Google Scholar
  2. Bakti, G., Fisch, H.U., Karlaganis, G., Minder, C. and Bircher, J. (1987). Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam. Hepatology 7:629–638.Google Scholar
  3. Bansky, G., Meier, P.J., Ziegler, W.H., Walser, H., Schmid, M. and Huber, M. (1985). Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1: 1324–1325.Google Scholar
  4. Basile, A.S. and Skolnick, P. (1986). Subcellular localization of “peripheral-type” binding sites for benzodiazepines in rat brain. J. Neurochem. 46:305–308.Google Scholar
  5. Basile, A.S., Gammal, S.H., Mullen, K.D., Jones, E.A. and Skolnick, P. (1988). Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy. J. Neurosci. 8:2414–2421.Google Scholar
  6. Basile, A.S., Gammal, S.H., Jones, E.A. and Skolnick, P. (1989). The GABAA receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand. J. Neurochem. 53:1057–1063.Google Scholar
  7. Basile, A.S., Ostrowski, N.L., Gammal, S.H., Jones, E.A. and Skolnick, P. (1990a). The GABAA receptor complex in hepatic encephalopathy: autoradiographic evidence for the presence of an endogenous benzodiazepine receptor ligand. Neuropsychopharmacology 3:61–71.Google Scholar
  8. Basile, A.S., Pannell, L., Jaouni, T., Gammal, S.H., Fales, H., Jones, E.A. and Skolnick, P. (1990b). Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy. Proc. Natl. Acad. Sci. USA 87:5263–5267.Google Scholar
  9. Basile, A.S. (1991). The contribution of endogenous benzodiazepine receptor ligands to the pathogenesis of hepatic encephalopathy. Synapse 7:141–150.Google Scholar
  10. Basile, A.S., Hughes, R.D., Harrison, P.M., Murata, Y., Pannell, L., Jones, E.A. et al. (1991). Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N. Engl. J. Med. 325:473–478.Google Scholar
  11. Basile, A.S. and Jones, E.A. (1997). Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology 25:1303–1305.Google Scholar
  12. Bassett, M.L., Mullen, K.D., Skolnick, P. and Jones, E.A. (1987). Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology 93:1069–1077.Google Scholar
  13. Bassett, M.L., Mullen, K.D., Scholz, B., Fenstermacher, J. and Jones, E.A. (1990). Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy. Gastroenterology 98: 47–757.Google Scholar
  14. Braestrup, C., Schmiechen, R., Neef, G., Nielsen, M. and Petersen E.N. (1982). Interaction of convulsive ligands with benzodiazepine receptors. Science 216:1241–1243.Google Scholar
  15. Butterworth, R.F., Giguère, J.-F., Michaud, J., Lavoie, J. and Pomier Layrargues, G. (1987). Ammonia: Key factor in the pathogenesis of hepatic encephalopathy. Neurochem. Pathol. 6:1–12.Google Scholar
  16. Conn, H.O. (1993). Hepatic encephalopathy. In: (L. Schiff and E.R. Schiff, eds). Diseases of the Liver. Lippincott, Philadelphia: 1036–1061.Google Scholar
  17. Ferenci, P., Herneth, A. and Steindl, P. (1996). Newer approaches to therapy of hepatic encephalopathy. Semin. Liver Dis. 16:329–338.Google Scholar
  18. Ferreira, M.R., Gammal, S.H. and Jones, E.A. (1997). Resistance to 3-mercaptopropionic acid-induced seizures in hepatic encephalopathy. Hepato-Gastroenterol. 44:766–769.Google Scholar
  19. Flannery, D.B., Hsia, Y.E. and Wolf, B. (1982). Current status of hyperammonaemia syndromes. Hepatology 2:495–506.Google Scholar
  20. Gammal, S.H., Basile, A.S., Geller, D., Skolnick, P. and Jones EA. (1990). Reversal of the behavioural and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology 11:371–378.Google Scholar
  21. Ha, J.-H. and Basile, A.S. (1996). Modulation of ligand binding to components of the GABAA receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromes. Brain Res. 720:35–44.Google Scholar
  22. Itzhak, Y., Roig-Cantisano, A., Dombro, R.S. and Norenberg, M.D. (1995). Acute liver failure and hyperammonaemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res. 705:345–348.Google Scholar
  23. Itzhak, Y. and Norenberg, M.D. (1994a). Ammonia-induced upregulation of peripheral-type benzodiazepine receptors in cultured astrocytes labeled with [3H]PK 11195. Neurosci. Lett. 177:35–38.Google Scholar
  24. Itzhak, Y. and Norenberg, M.D. (1994b). Attenuation of ammonia toxicity in mice by PK 11195 and pregnenolone sulfate. Neurosci. Lett. 182:251–254.Google Scholar
  25. Jones, D.B., Mullen, K.D., Roessle, M., Maynard, T. and Jones, E.A. (1987). Hepatic encephalopathy: application of visual evoked responses to test hypotheses of its pathogenesis in rats. J. Hepatol. 4:118–126.Google Scholar
  26. Jones, E.A., Yurdaydin, C. and Basile, A.S. (1994). The GABA hypothesis — State-of-the-art. Adv. Exp. Biol. Med. 368: 89–101.Google Scholar
  27. Lambert, J.J., Belelli, D., Hill-Venning, C. and Peters, J.A. (1995). Neurosteroids and GABAA receptor function. Trends Pharmacol. Sci. 6:295–303.Google Scholar
  28. Maddison, J.E., Dodd, P.R., Morrison, M., Johnson, G.A.R. and Farrell, G.C. (1987). Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy. Hepatology 7:621–628.Google Scholar
  29. Majewska, M.D., Harrison, N.L., Schwartz, R.D, Barker, J.L. and Paul, S.M. (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004–1007.Google Scholar
  30. Majewska, M.D. and Schwartz R.D. (1987). Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain? Brain Res. 404:355–360.Google Scholar
  31. Oja, S.S., Saransaari, P., Wysmyk, U. and Albrecht, J. (1993). Loss of GABAB binding sites in the cerebral cortex of rats with acute hepatic encephalopathy. Brain Res. 629:355–357.Google Scholar
  32. Olasmaa, M., Rothstein, J.D., Guidotti, A., Weber, R.J., Paul, S.M., Spector, S. et al. (1990). Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J. Neurochem. 55:2015–2033.Google Scholar
  33. Pappas, S.C., Ferenci, P., Schafer, D.F. and Jones, E.A. (1984). Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonaemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins. Gastroenterology 86:546–551.Google Scholar
  34. Raabe, W.A. (1989). Neurophysiology of ammonia intoxication. In: (R.F. Butterworth and G. Pomier Layrarques, eds). Hepatic encephalopathy. Pathophysiology and Treatment. Humana, Clifton NJ, 49–77.Google Scholar
  35. Rossle, M., Deckert, J. and Jones, E.A. (1989a). Autoradiographic analysis of GABA/ benzodiazepine receptors in an animal model of acute hepatic encephalopathy. Hepatology 10:143–147.Google Scholar
  36. Rossle, M., Mullen, K.D. and Jones, E.A. (1989b). Cortical benzodiazepine receptor binding in a rabbit model of hepatic encephalopathy: the effect of Triton X-100 on receptor solubilization. Metab. Brain Dis. 4:203–212.Google Scholar
  37. Roy, S., Pomier Layrargues, G., Butterworth, R.F. and Huet, P.-M. (1988). Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: Lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors. Hepatology 8:845–849.Google Scholar
  38. Rzepczynski, D., Zieve, L., Lindblad, S. and LaFontaine, D. (1986). In vivo studies of GABAergic effects in experimental hepatic encephalopathy. Hepatology 5:902–905.Google Scholar
  39. Schafer, D.F., Fowler, J.M., Brody, L.E. and Jones, E.A. (1980). Hepatic coma and inhibitory neurotransmission: the enteric bacterial flora as a source of gamma-aminobutyric acid. Gastroenterology 79:1052.Google Scholar
  40. Schafer, D.F. and Jones, E.A. (1982). Hepatic encephalopathy and the gamma-aminobutyric acid neurotransmitter system. Lancet 1:18–20.Google Scholar
  41. Schafer, D.F., Fowler, J.M., Munson, P.J., Thakur, A.K., Waggoner, J.G. and Jones, E.A. (1983). Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. J. Lab. Clin. Med. 102:870–880.Google Scholar
  42. Schafer, D.F., Pappas, S.C., Brody, L.E., Jacobs, R. and Jones, E.A. (1984). Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas. Gastroenterology 86:540–545.Google Scholar
  43. Scollo-Lavizzari, G. and Steinmann, E. (1985). Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1:1324.Google Scholar
  44. Study, R. and Barker, J. (1981). Diazepam and (−)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc. Natl. Acad. Sci. USA 77:7486–7472.Google Scholar
  45. Takahashi, K., Kameda, H., Kataoka, M., Sanjou, K., Harata, N. and Akaike, N. (1993). Ammonia potentiates GABAA response in dissociated rat cortical neurons. Neurosci. Lett. 151:51–54.Google Scholar
  46. Willow, M. and Johnson, G.A.R. (1981). Dual action of pentobarbitone on GABA binding: role of binding site integrity. J. Neurochem. 37:1291–1294.Google Scholar

Copyright information

© Plenum Publishing Corporation 1998

Authors and Affiliations

  • E. Anthony Jones
    • 1
  • Anthony S. Basile
    • 2
  1. 1.Department of Gastrointestinal and Liver DiseasesAcademic Medical CenterAmsterdamThe Netherlands
  2. 2.Laboratory of NeuroscienceNIDDK, National Institutes of HealthBethesda

Personalised recommendations